The IMvigor010 trial showed that Signatera-guided treatment with Tecentriq improved disease-free survival and overall ...
The trial showed that 63% of patients achieved a complete response (CR) at any time after receiving detalimogene coraplasmid.
2don MSN
How scientists are hacking bacteria to treat cancer, self-destruct, then vanish without a trace
Bacteria can serve as couriers for these anti-cancer vaccines. Using genetic engineering, the genetic instructions (or DNA) ...
Are you cancer-aware?
Probiotic species used in humans for many years are also candidates, including Escherichia coli Nissle, Lactobacillus and ...
Urology Care Foundation Flushes Out Myths for Bladder Health Month November is Bladder Health Month, and the Urology Care ...
Although doggy diapers can help, they don’t address the root of the problem. Here’s what to know about dogs and urinary ...
Cancer continues to be one of the most challenging diseases of our time, but prevention still remains one of our strongest ...
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. BERLIN — For years, scientists have held out hope that tests that look ...
Welltica+ on MSN
Tiny implant eliminates bladder cancer in 82% of patients
A new slow-release implant has shown unprecedented success in wiping out bladder cancer in more than 80 percent of patients, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback